Article
Limited and defined truncation at the C terminus enhances receptor binding and degranulation activity of the neutrophil-activating peptide 2 (NAP-2). Comparison of native and recombinant NAP-2 variants.
The Journal of biological chemistry - 17 Mar 1995
Ehlert J E, Petersen F, Kubbutat M H, Gerdes J, Flad H D, Brandt E
Abstract excerpt
We have previously described a C-terminally truncated variant of the chemokine neutrophil-activating peptide 2 (NAP-2) that exhibited higher neutrophil-stimulating capacity than the full-size polypeptide. To investigate the impact of the NAP-2 C terminus on biological activity and receptor binding, we have now purified the novel molecule to homogeneity. Furthermore, we have cloned, expressed in Escherichia coli,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
